You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Russo EE, Zovko LE, Nazari R, et al. (2023) Evaluation and Validation of Commercially Available Dopamine Transporter Antibodies. Eneuro. 10
Mielnik CA, Li CK, Ramsey AJ, et al. (2022) Cannabidiol, but Not Δ9-Tetrahydrocannabinol, Has Strain- and Genotype-Specific Effects in Models of Psychosis. Cannabis and Cannabinoid Research
Lipina T, Men X, Blundell M, et al. (2022) Abnormal sensory perception masks behavioral performance of Grin1 knockdown mice. Genes, Brain, and Behavior. e12825
Sutton C, Williams EQ, Homsi H, et al. (2022) Structure-Activity Relationships of Dopamine Transporter Pharmacological Chaperones. Frontiers in Cellular Neuroscience. 16: 832536
Vecchio LM, Sullivan P, Dunn AR, et al. (2021) Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo. Journal of Neurochemistry
Mielnik CA, Sugamori KS, Finlay DB, et al. (2020) A novel allosteric modulator of the cannabinoid CB receptor ameliorates hyperdopaminergia endophenotypes in rodent models. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Mielnik CA, Binko MA, Chen Y, et al. (2020) Consequences of NMDA receptor deficiency can be rescued in the adult brain. Molecular Psychiatry
Intson K, van Eede MC, Islam R, et al. (2019) Progressive neuroanatomical changes caused by Grin1 loss-of-function mutation. Neurobiology of Disease. 104527
Chen Y, Milenkovic M, Horsfall W, et al. (2018) Restoring striatal WAVE-1 improves maze exploration performance of GluN1 knockdown mice. Plos One. 13: e0199341
Lam VM, Mielnik CA, Baimel C, et al. (2018) Behavioral Effects of a Potential Novel TAAR1 Antagonist. Frontiers in Pharmacology. 9: 953